Skip to content

An RCT on Preventing Pressure Ulcers With Wheelchair Seat Cushions

An RCT on Preventing Pressure Ulcers With Seat Cushions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00178126
Enrollment
232
Registered
2005-09-15
Start date
2004-03-31
Completion date
2008-10-31
Last updated
2017-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure Ulcer

Keywords

pressure ulcer

Brief summary

The primary aim of the proposed multi-site, randomized pressure-reducing wheelchair trial (PRWC-II) is to determine the efficacy of pressure-reducing cushions in preventing sitting-acquired pressure ulcers in the elderly, nursing home population. Positive results of the proposed trial will provide the level of evidence needed to change the standard of care to include the routine evaluation of at-risk residents for seating and positioning needs and the provision of pressure-reducing cushions as a preventive measure against sitting-acquired pressure ulcers. If our hypothesis is valid, such intervention should result in a decrease in the incidence and prevalence of sitting-acquired pressure ulcers, reduced healthcare costs, and improved quality of life.

Detailed description

Pressure ulcers (aka pressure sores, bed sores and decubitus ulcers) are a significant healthcare problem for the growing number of United States elderly long-term care (LTC) residents. Pressure ulcers (PU) diminish quality of life, exact a devastating loss of function, increase the risk of death in geriatric populations and raise healthcare costs. Despite Federal preventive mandates for the long-term care (LTC) setting, widespread non-compliance occurs. The last three Centers for Medicare and Medicaid Services (CMS) LTC surveys showed a cumulative increase of 21% in the number of citations issued for failure to provide proper intervention to prevent or treat pressure ulcers. Costs for the management of PU in the US likely exceed $6.4 billion annually with a prevalence of approximately 28% in the LTC population. Estimates of the number of sitting-acquired PU in the elderly, at-risk population range from 36-50%. Several studies, including our own pilot investigation, support these estimates and have suggested that the use of wheelchair cushions designed to reduce interface pressure will reduce the incidence of sitting-acquired PU. Despite this evidence, elderly wheelchair users are not routinely evaluated for seating and positioning needs as definitive studies have not been completed to justify funding for such seating interventions. Consequently, elderly Medicare beneficiaries are being denied access to medically necessary and clinically appropriate interventions and instead are most frequently provided with convoluted or segmented-foam cushions that are not designed for pressure ulcer prevention. The primary aim of the proposed multi-site, randomized pressure-reducing wheelchair trial (PRWC-II) is to determine the efficacy of pressure-reducing cushions in preventing sitting-acquired pressure ulcers in the elderly, nursing home population. Positive results of the proposed trial will provide the level of evidence needed to change the standard of care to include the routine evaluation of at-risk residents for seating and positioning needs and the provision of pressure-reducing cushions as a preventive measure against sitting-acquired pressure ulcers. If our hypothesis is valid, such intervention should result in a decrease in the incidence and prevalence of sitting-acquired pressure ulcers, reduced healthcare costs, and improved quality of life.

Interventions

DEVICESkin Protection Wheelchair Seat Cushion

Cushion receiving CMS code for Skin Protection Wheelchair Cushion

DEVICESegmented Foam Wheelchair Seat Cushion

General use class wheelchair seat cushion

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 65 and older * use wheelchair \> 6 hours per day * no pressure ulcer on sitting surface * Braden score of 18 or less * combined activity and mobility Braden sub-score of 5 or less

Exclusion criteria

* Body Weight exceeds 250 lbs. * Hip Width exceeds 20 inches * does not meet all criteria of seating needs assessment * current use of cushioning material or wheelchair better than study devices

Design outcomes

Primary

MeasureTime frame
Sitting-induced Pressure Ulcers6 months

Countries

United States

Participant flow

Participants by arm

ArmCount
Segmented Foam Cushion
Receive seating assessment, wheelchair and seat cushion representing the standard of care in nursing homes Segmented Foam Wheelchair Seat Cushion: General use class wheelchair seat cushion
119
Skin Protection Cushion
Receive seating assessment, wheelchair and cushion meeting CMS code for Skin Protection Wheelchair Cushion Skin Protection Wheelchair Seat Cushion: Cushion receiving CMS code for Skin Protection Wheelchair Cushion
113
Total232

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studydid not receive intervention46
Overall StudyLost to Follow-up2121

Baseline characteristics

CharacteristicSegmented Foam CushionSkin Protection CushionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
119 Participants113 Participants232 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous86.5 years
STANDARD_DEVIATION 7.7
86.7 years
STANDARD_DEVIATION 7.4
86.6 years
STANDARD_DEVIATION 7.6
Body Mass Index25.0 kg/m^2
STANDARD_DEVIATION 5.2
24.6 kg/m^2
STANDARD_DEVIATION 4.4
24.8 kg/m^2
STANDARD_DEVIATION 4.8
Incontinence97 participants97 participants194 participants
Sex: Female, Male
Female
106 Participants91 Participants197 Participants
Sex: Female, Male
Male
13 Participants22 Participants35 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1190 / 113
serious
Total, serious adverse events
0 / 1190 / 113

Outcome results

Primary

Sitting-induced Pressure Ulcers

Time frame: 6 months

ArmMeasureValue (NUMBER)
Segmented Foam CushionSitting-induced Pressure Ulcers8 participants
Skin Protection CushionSitting-induced Pressure Ulcers1 participants
p-value: 0.04Fisher Exact

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026